The global endometriosis treatment market was valued at USD 1.4 Bn in 2023 and is projected to reach USD 3.1 Bn by the end of 2034, growing at a CAGR of 7.5% from 2024 to 2034. Market growth is driven by rising awareness of endometriosis, increasing diagnosis rates, advancements in hormonal and non-hormonal therapies, and improved access to specialized women’s healthcare worldwide. Rise...